The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...

The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or ...

A research team was looking to make a new anti-inflammatory medication when they found some incredible side effects ...

The traditional approach to trial management relies on a mix of solutions that often become siloed and difficult to integrate ...

A mentorship program for neonatal nurse practitioners in Tennessee receives positive feedback from mentor and mentee ...

Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...

The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...

CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...

Creatine, a naturally occurring compound, enhances athletic performance and shows potential health benefits, but caution and ...